Cargando…
Safety of tiotropium in patients with asthma
Given the high proportion of patients with asthma who remain uncontrolled despite controller treatment, there remains a need for the development of more effective treatment options with a proven safety and tolerability profile. Recently, asthma guidelines have evolved to incorporate new therapies, i...
Autores principales: | Dusser, Daniel, Ducharme, Francine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391545/ https://www.ncbi.nlm.nih.gov/pubmed/30795731 http://dx.doi.org/10.1177/1753466618824010 |
Ejemplares similares
-
Tiotropium bromide as adjunct therapy in children with asthma: a clinical experience
por: Ridha, Zainab, et al.
Publicado: (2021) -
The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes
por: Anzueto, Antonio, et al.
Publicado: (2015) -
The evolving role of tiotropium in asthma
por: McIvor, Emma R, et al.
Publicado: (2017) -
Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial
por: Dahl, Ronald, et al.
Publicado: (2015) -
The role of tiotropium in the management of asthma
por: Park, Heung-Woo
Publicado: (2012)